Abortion, Medical

2

Review clinical trials related to Abortion, Medical. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Foley Balloon for Cervical Preparation Before Dilation and Evacuation

To evaluate the Foley Balloon technique for cervical preparation before second trimester surgical abortion between 16 and 21 weeks estimated gestational age in combination with misoprostol to prepare the cervix before dilation and evacuation (D\&E) instead of osmotic dilators (Laminaria). Specific Aim One: Assess definitively whether using a Foley Balloon and Misoprostol is non-inferior to osmotic dilators for cervical preparation before D\&E. Specific Aim Two: Evaluate patient satisfaction with the two methods of second trimester abortion. Specific Aim Three: Evaluate provider satisfaction with the two methods of second trimester abortion.

Participants needed: 102
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Stony Brook UniversityUpdated: Apr 30, 2026Locations: 1
Eligibility criteria

Women 18 years and older presenting to Hospital Central de Maputo requiring abor... [+1]

Less than age 18 [+10]

Status: Not yet recruiting

The Misoprostol-Only Regimen Evidence Study

The goal of this study is to evaluate the effectiveness, non-inferiority, and side-effect profile of an updated misoprostol-only regimen, as compared to the combined mifepristone-misoprostol regimen, among people seeking medication abortion (MAB) through 77 days of pregnancy in telehealth and in-person settings. The investigators aim to evaluate this in both in-clinic and telehealth medication abortion care in the United States. The main questions it aims to answer are: 1. What proportion of pregnant people using an updated misoprostol-only medication abortion regimen have a complete abortion using just the prescribed pills? 2. Is the updated misoprostol-only medication abortion regimen no more than 5% less effective (non-inferior) than the standard combined medication abortion regimen? 3. What is the pattern of beta hCG decline following use of a misoprostol-only medication abortion through 77 days of pregnancy? Participants will: * be randomized to one of two medication regimens (misoprostol-only or the combined regimen) in a 1:1 ratio based on duration of pregnancy at enrollment. - self-report outcomes via daily surveys for the first 3 days, and thereafter weekly at 7, 14, 21, 28, and 35 days. * return to the clinical site for tests as instructed The investigators hypothesize that the proportion with complete abortions in the misoprostol-only arm will be non-inferior to the proportion with complete abortions in the combined regimen arm within a 5% margin of inferiority

Participants needed: 1,900
Trial details
Phase: Phase 4Age: 14+Biological sex: FemaleType: InterventionalSponsor: Ibis Reproductive HealthUpdated: Oct 8, 2025Locations: 1
Eligibility criteria

Pregnancy of < or = 77 days duration based on LMP or ultrasound [+8]

concurrent participation in any other interventional trial [+13]